Rheumatic Disease Clinics of North America

Papers
(The median citation count of Rheumatic Disease Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Racial/Ethnic, Socioeconomic, and Geographic Disparities in the Epidemiology of Knee and Hip Osteoarthritis40
Risk Factors and Cancer Screening in Myositis26
Rheumatoid Arthritis25
Osteoarthritis Treatment Guidelines from Six Professional Societies24
Racial/Ethnic and Socioeconomic Disparities in Osteoarthritis Management24
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis24
Gender and Ethnic Inequities in Gout Burden and Management23
Axial Psoriatic Arthritis22
Basic Mechanisms of Pain in Osteoarthritis22
Understanding Lupus Disparities Through a Social Determinants of Health Framework21
Cancer and Systemic Lupus Erythematosus21
Treatment Guidelines in Rheumatoid Arthritis18
Cancer and Rheumatoid Arthritis18
COVID-19 in Pediatrics14
Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries14
Cancer and Scleroderma14
Systemic Lupus Erythematosus Classification and Diagnosis14
Socioeconomic Status, Health Care, and Outcomes in Systemic Lupus Erythematosus14
(Health-Related) Quality of Life as an Outcome in Studies of Axial Spondyloarthritis13
Classification Criteria in Axial Spondyloarthritis13
Health Disparities in Systemic Lupus Erythematosus13
Targeting Nerve Growth Factor for Pain Management in Osteoarthritis—Clinical Efficacy and Safety12
Risk of Malignancy in Spondyloarthritis12
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus12
Recent Updates in Juvenile Spondyloarthritis12
Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus12
Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms12
B Cells in Systemic Lupus Erythematosus12
Racial Disparities in Systemic Sclerosis11
Racial Disparities in Rheumatology Through the Lens of Critical Race Theory11
Juvenile-Versus Adult-Onset Spondyloarthritis10
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus10
Sjögren Syndrome and Cancer10
Treat to Target in Axial Spondyloarthritis10
Juvenile Localized Scleroderma9
The Power of Systems Biology9
Low Back Pain in Adolescent and Geriatric Populations9
Interferons in Systemic Lupus Erythematosus9
Pathogenesis of Axial Spondyloarthritis — Sources and Current State of Knowledge8
Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity8
Intestinal Microbiota, HLA-B27, and Spondyloarthritis8
Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes8
Mental Health in Pediatric Rheumatology7
The Temporomandibular Joint in Juvenile Idiopathic Arthritis7
Health Disparities in Rheumatic Diseases7
T Cells in Systemic Lupus Erythematosus7
Disparities in Childhood-Onset Lupus7
Paraneoplastic Musculoskeletal Syndromes7
Pain Mechanisms in Patients with Rheumatic Diseases7
Understanding the Disproportionate Burden of Rheumatic Diseases in Indigenous North American Populations6
The Categorization of Pain in Systemic Lupus Erythematosus6
Juvenile Idiopathic Arthritis Treatment Updates6
Management of Pregnancy in Lupus6
Systemic Autoinflammatory Diseases6
What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis?6
Uveitis in Children and Adolescents6
Environmental Triggers of Hyperuricemia and Gout6
Recommendations for Systemic Lupus Erythematosus6
Chronic Nonbacterial Osteomyelitis6
Treatment Update in Systemic Lupus Erythematous6
Emerging Imaging Techniques in Spondyloarthritis6
Designing an Intervention to Improve Management of High-Risk Lupus Patients Through Care Coordination6
Leveraging Telemedicine as an Approach to Address Rheumatic Disease Health Disparities6
Pain in Axial Spondyloarthritis5
Disparities in Pediatric Rheumatic Diseases5
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma5
Fibromyalgia5
Understanding Risk Factors for Poor Outcomes in a Multiethnic Longitudinal Cohort5
The Contribution of Genetics and Epigenetics to Our Understanding of Health Disparities in Rheumatic Diseases5
Juvenile Fibromyalgia5
Unique Aspects of Pediatric Sjögren Disease5
Ultrasonography in Pediatric Rheumatology5
Pharmacosurveillance in Juvenile Idiopathic Arthritis5
Behçet Syndrome5
Why It Hurts5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis4
Implementation Science in Pediatric Rheumatology: A Path to Health Equity4
Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis4
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model4
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development4
The Patient’s Perspective on the Burden of Disease in Ankylosing Spondylitis4
Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials4
Treatment Guidelines in Vasculitis4
Cardiovascular Health in Pediatric Rheumatologic Diseases4
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children4
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis4
Axial Spondyloarthritis in the Era of Precision Medicine4
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy4
Increasing Ancestral Diversity in Lupus Trials3
CARRA3
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury3
The Future of Imaging in Axial Spondyloarthritis3
Environmental Risks for Spondyloarthropathies3
Immune Checkpoint Inhibition—Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity3
Can Imaging Be a Proxy for Remission in Axial Spondyloarthritis?3
Using the Electronic Health Record to Enhance Care in Pediatric Rheumatology3
Nonpharmacologic Pain Management in Inflammatory Arthritis3
Giant Cell Arteritis and Polymyalgia Rheumatica3
The GRADE Method3
Managing Cardiovascular Risk in Patients with Rheumatic Disease3
Treatment Guidelines in Gout3
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk3
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis3
The Future of Axial Spondyloathritis Treatment3
Molecular Biology Approaches to Understanding Spondyloarthritis3
Interstitial Lung Disease3
Central Nervous System Vasculitis2
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica2
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease2
Management of Knee Osteoarthritis2
Management and Cure of Gouty Arthritis2
Vasculitis and Pregnancy2
Community-Engaged Research: Leveraging Community-Academic Partnerships to Reduce Disparities and Inequities in Lupus Care2
Recent Advances in Pediatric Vasculitis2
AS Patient2
Gastrointestinal Tract Considerations: Part II2
Inhalant and Additional Mucosal-Related Environmental Risks for Rheumatoid Arthritis2
Treatment of Vascular Complications in Systemic Sclerosis2
Innovative Trials and New Opportunities in SLE2
Spondyloarthritis: The Changing Landscape—Are We There Yet?2
The Promises and Perils of Social Media for Pediatric Rheumatology2
Gastrointestinal Tract Considerations Part I2
Precision Medicine2
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus2
Rheumatic Complications of Immune Checkpoint Inhibitors2
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis2
Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease2
Overview of the Associations Between Cancer and Rheumatic Disease2
Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome2
Venous Thromboembolism in the Inflammatory Rheumatic Diseases2
Patient Engagement in Pediatric Rheumatology Research2
Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis2
Systemic Lupus Erythematosus Risk2
Environmental Risks for Inflammatory Myopathies2
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis2
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus1
Health Disparities in Rheumatic Diseases: Part II1
Lupus Cohorts1
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases1
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy1
Health Care Utilization1
Health Disparities in Rheumatic Diseases: Part I1
Environmental Risks for Systemic Sclerosis1
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis1
The Exciting Future for Scleroderma1
Heart Failure in Rheumatic Disease1
How the American College of Rheumatology Develops Guidelines1
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis1
Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases:1
Environmental Triggers for Vasculitis1
Cannabinoids and Pain1
Systemic Lupus Erythematosus: The Next Generation of Ideas and Scientists1
Role of Environment in Pediatric Rheumatic Diseases1
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy1
Perioperative Management of Rheumatic Disease and Therapies1
Pulmonary Hypertension1
The Emerging Telehealth Landscape in Pediatric Rheumatology1
NF-κB and Related Autoimmune and Autoinflammatory Diseases1
Patient Experience of Systemic Sclerosis–Related Calcinosis1
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases1
Taxonomy of Quality of Care Indicators1
Statin-Associated Myalgias and Muscle Injury—Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein1
Genetic Defects in Early-Onset Inflammatory Bowel Disease1
Patient-Reported Outcomes in Lupus1
0.049834966659546